SkinBioTherapeutics plc (AIM: SBTX)

SkinBioTherapeutics Revenue

SkinBioTherapeutics had revenue of 106.58K GBP in the half year ending December 31, 2023, with 385.56% growth. This brings the company's revenue in the last twelve months to 161.65K, up 24.54% year-over-year. In the fiscal year ending June 30, 2023, SkinBioTherapeutics had annual revenue of 132.06K with 76.64% growth.

• Revenue (ttm): 161.65K
• Revenue Growth: +24.54%
• P/S Ratio: 128.52
• Revenue / Employee: 14.70K
• Employees: 11
• Market Cap: 26.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	132.06K	57.30K	76.64%
Jun 30, 2022	74.76K	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-
Jun 30, 2019	-	-	-